← back to database
We focus on high-growth, disruptive businesses with innovative products and services that have a proven business model in sectors where we believe the upside is enormous.
Primary stage
Lead / follow
Initial check size
Ownership target
Hardware / software
B2B / B2C
Investment focus
Does not invest in
Biotech, pharma
Investors
Andy Appelbaum, Spencer Krug, Danny Cohen